Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American ...
—KB-0742 continues to demonstrate a manageable safety and tolerability profile with no grade 3/4 neutropenia observed—
Source: eagletribune.com
Briana Van News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Briana Van. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Briana Van Today - Breaking & Trending Today
Some sarcoma patients improve with T cell immunotherapy - The Source - Washington University in St. Louis
According to a study led by Washington University School of Medicine in St. Louis, a new T cell immunotherapy — in which the patients’ own T cells are genetically modified to attack and kill cancer cells — is effective in treating some patients with two types of sarcoma, rare cancers of the body’s soft tissues.
Source: wustl.edu
Adaptimmune Reports Better Outcomes for People with Synovial Sarcoma who Received Afami-cel Compared to Historical Control
Adaptimmune Therapeutics plc , a leader in cell therapy to treat cancer, to present outcome data from Cohort 1 of its pivotal SPEARHEAD-1 trial at the Connective Tissue Oncology Society annual...
Source: marketscreener.com
Dr Van Tine on the SPEARHEAD-1 Trial of Afami-Cel in Advanced Synovial Sarcoma
Brian A. Van Tine, MD, PhD, discusses findings from the overall survival analysis of the phase 2 SPEARHEAD-1 trial in patients with advanced synovial sarcoma.
Source: onclive.com
Dr Van Tine on Investigating Cabozantinib With PD-1 and CTLA-4 Inhibition in Sarcoma
Brian A. Van Tine, MD, PhD, discusses the rationale for launching a randomized phase 2 trial investigating cabozantinib combined with nivolumab and ipilimumab vs cabozantinib alone in metastatic soft tissue sarcoma and discusses key findings from the trial.
Source: onclive.com